Details for: CD47
Gene ID: 961
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: CD47
Ensembl ID: ENSG00000196776
Description: CD47 molecule
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 82.22rCSI 79.15%PRS 13.16
-
CSI 53.78rCSI 47.29%PRS 9.22
-
CSI 41.23rCSI 69.2%PRS 7.47
-
CSI 37.72rCSI 91.66%PRS 7.27
-
CSI 32.62rCSI 61.58%PRS 15.76
-
CSI 31.91rCSI 24.59%PRS 11.52
-
CSI 30.28rCSI 94.64%PRS 7.99
-
CSI 29.32rCSI 36.47%PRS 6.95
-
CSI 28.59rCSI 55.61%PRS 12.98
-
CSI 26.95rCSI 24.34%PRS 11.24
-
CSI 26.28rCSI 40.06%PRS 11.89
-
CSI 24.61rCSI 93.02%PRS 7.61
-
CSI 24.23rCSI 32.21%PRS 13.89
-
CSI 24.01rCSI 75.1%PRS 8.57
-
CSI 23.9rCSI 86%PRS 6.92
-
CSI 22.52rCSI 23.59%PRS 13.59
-
CSI 18.59rCSI 14.06%PRS 17.57
-
CSI 17.89rCSI 23.06%PRS 7.82
-
CSI 15.85rCSI 18.93%PRS 7.33
-
CSI 15.72rCSI 92.54%PRS 7.81
-
CSI 15.44rCSI 33.49%PRS 6.97
-
CSI 14.9rCSI 52.27%PRS 23.03
-
CSI 14.43rCSI 20.81%PRS 17.68
-
CSI 14.36rCSI 14.12%PRS 13.82
-
CSI 14.18rCSI 41.03%PRS 28.2
-
CSI 13.43rCSI 35.77%PRS 10.01
-
CSI 13.28rCSI 16.67%PRS 16.18
-
CSI 13.09rCSI 43.03%PRS 6.54
-
CSI 13.05rCSI 42.73%PRS 35.47
-
CSI 12.55rCSI 17.1%PRS 11.34
-
CSI 11.3rCSI 56.17%PRS 13.84
-
CSI 10.74rCSI 7.14%PRS 15.15
-
CSI 10.49rCSI 51.7%PRS 17.3
-
CSI 10.37rCSI 16.03%PRS 11.9
-
CSI 10.27rCSI 9.43%PRS 14.54
-
CSI 10.27rCSI 15.93%PRS 19.32
-
CSI 10.11rCSI 17.81%PRS 12.55
-
CSI 9.98rCSI 11.43%PRS 26.07
-
CSI 9.84rCSI 38.98%PRS 18
-
CSI 9.81rCSI 50.67%PRS 24.97
-
CSI 9.08rCSI 25.92%PRS 21.94
-
CSI 8.83rCSI 6.17%PRS 13.32
-
CSI 8.23rCSI 11.31%PRS 26.18
-
CSI 8.2rCSI 5.46%PRS 33.05
-
CSI 7.91rCSI 18.97%PRS 23.05
-
CSI 7.79rCSI 33.79%PRS 22.82
-
CSI 7.68rCSI 56.49%PRS 6.48
-
CSI 7.39rCSI 83.15%PRS 31.95
-
CSI 7.17rCSI 11.54%PRS 9.77
-
CSI 6.97rCSI 40.19%PRS 16.91
-
CSI 6.92rCSI 19.92%PRS 24.67
-
CSI 6.23rCSI 14.9%PRS 6.98
-
CSI 6.16rCSI 7.12%PRS 9.31
-
CSI 6.06rCSI 6.44%PRS 22.59
-
CSI 6.01rCSI 4.18%PRS 14.88
-
CSI 5.69rCSI 9.73%PRS 25.33
-
CSI 5.61rCSI 6.94%PRS 11.15
-
CSI 5.58rCSI 4.32%PRS 12.11
-
CSI 5.57rCSI 4.17%PRS 20.6
-
CSI 5.2rCSI 4.11%PRS 8.73
-
CSI 5.05rCSI 33.15%PRS 32.76
-
CSI 4.6rCSI 6.74%PRS 14.85
-
CSI 4.49rCSI 4.62%PRS 20.72
-
CSI 4.31rCSI 16.15%PRS 10.77
-
CSI 4.24rCSI 25.02%PRS 13.26
-
CSI 4.17rCSI 33.88%PRS 13.15
-
CSI 4.11rCSI 16%PRS 20.83
-
CSI 4.1rCSI 5.61%PRS 14.42
-
CSI 4.09rCSI 3.94%PRS 8.75
-
CSI 4.07rCSI 3.29%PRS 12.54
-
CSI 4.07rCSI 5.99%PRS 11.64
-
CSI 4.05rCSI 4.75%PRS 14.96
-
CSI 4.04rCSI 7.13%PRS 7.43
-
CSI 3.9rCSI 2.91%PRS 21.31
-
CSI 3.8rCSI 3.87%PRS 18.16
-
CSI 3.8rCSI 90.93%PRS 5.75
-
CSI 3.75rCSI 90.44%PRS 6.63
-
CSI 3.7rCSI 16.44%PRS 12.54
-
CSI 3.7rCSI 5.41%PRS 13.43
-
CSI 3.68rCSI 5.63%PRS 14.55
-
CSI 3.68rCSI 22.72%PRS 41.09
-
CSI 3.64rCSI 5.04%PRS 18.29
-
CSI 3.6rCSI 2.98%PRS 11.99
-
CSI 3.57rCSI 3.11%PRS 15.68
-
CSI 3.53rCSI 4.14%PRS 16.96
-
CSI 3.52rCSI 2.47%PRS 32.74
-
CSI 3.44rCSI 3.58%PRS 13.02
-
CSI 3.35rCSI 2.48%PRS 11.28
-
CSI 3.33rCSI 11.83%PRS 39.37
-
CSI 3.26rCSI 3.67%PRS 20.33
-
CSI 3.2rCSI 2.3%PRS 17.26
-
CSI 3.19rCSI 12.69%PRS 22.37
-
CSI 3.1rCSI 33.93%PRS 22.94
-
CSI 3.09rCSI 5.95%PRS 28.41
-
CSI 3.08rCSI 2.14%PRS 18.05
-
CSI 3.06rCSI 23.97%PRS 27.59
-
CSI 2.93rCSI 2.51%PRS 22.31
-
CSI 2.93rCSI 73.82%PRS 40.16
-
CSI 2.8rCSI 3.59%PRS 49.77
-
CSI 2.8rCSI 4.45%PRS 10.9
-
CSI -9.5rCSI -13.7%PRS 17.4%
-
CSI -3.8rCSI -21.5%PRS 5.2%
-
CSI -3.6rCSI -9.1%PRS 36.8%
-
CSI -2.9rCSI -14.0%PRS 8.4%
-
CSI -2.9rCSI -5.8%PRS 13.5%
-
CSI -2.5rCSI -3.7%PRS 14.7%
-
CSI -2.0rCSI -3.9%PRS 20.2%
-
CSI -1.7rCSI -2.7%PRS 12.7%
-
CSI -1.5rCSI -25.6%PRS 48.5%
-
CSI -1.3rCSI -3.1%PRS 19.8%
-
CSI -1.1rCSI -1.4%PRS 17.8%
-
CSI -0.9rCSI -6.0%PRS 24.9%
-
CSI -0.8rCSI -1.3%PRS 25.5%
-
CSI -0.4rCSI -0.6%PRS 10.9%
-
CSI -0.3rCSI -1.7%PRS 49.7%
-
CSI -0.1rCSI -0.5%PRS 19.3%
-
CSI -0.1rCSI -0.8%PRS 34.5%
-
CSI 0.1rCSI 0.2%PRS 24.3%
-
CSI 0.1rCSI 0.3%PRS 9.9%
-
CSI 0.1rCSI 1.1%PRS 36.2%
-
CSI 0.1rCSI 0.3%PRS 16.4%
-
CSI 0.1rCSI 0.6%PRS 18.6%
-
CSI 0.1rCSI 1.2%PRS 47.4%
-
CSI 0.1rCSI 1.8%PRS 40.8%
-
CSI 0.1rCSI 1.8%PRS 46.9%
-
CSI 0.1rCSI 0.4%PRS 17.9%
-
CSI 0.1rCSI 0.5%PRS 13.6%
-
CSI 0.1rCSI 1.2%PRS 60.5%
-
CSI 0.2rCSI 0.8%PRS 42.4%
-
CSI 0.2rCSI 0.2%PRS 18.7%
-
CSI 0.2rCSI 0.4%PRS 9.7%
-
CSI 0.2rCSI 0.4%PRS 12.5%
-
CSI 0.2rCSI 2.5%PRS 31.4%
-
CSI 0.2rCSI 2.6%PRS 39.4%
-
CSI 0.2rCSI 0.5%PRS 31.4%
-
CSI 0.2rCSI 0.2%PRS 14.8%
-
CSI 0.2rCSI 3.8%PRS 9.8%
-
CSI 0.2rCSI 0.4%PRS 11.9%
-
CSI 0.2rCSI 0.8%PRS 27.8%
-
CSI 0.2rCSI 0.3%PRS 16.4%
-
CSI 0.2rCSI 0.7%PRS 10.8%
-
CSI 0.3rCSI 1.6%PRS 34.9%
-
CSI 0.3rCSI 0.5%PRS 10.4%
-
CSI 0.3rCSI 1.5%PRS 19.6%
-
CSI 0.3rCSI 1.2%PRS 26.3%
-
CSI 0.3rCSI 1.7%PRS 40.3%
-
CSI 0.3rCSI 0.6%PRS 20.5%
-
CSI 0.3rCSI 0.5%PRS 16.8%
-
CSI 0.3rCSI 2.1%PRS 23.3%
-
CSI 0.3rCSI 0.8%PRS 20.9%
-
CSI 0.3rCSI 2.8%PRS 37.2%
-
CSI 0.3rCSI 0.8%PRS 15.2%
-
CSI 0.3rCSI 0.7%PRS 19.2%
-
CSI 0.3rCSI 6.5%PRS 60.6%
-
CSI 0.3rCSI 0.9%PRS 20.9%
-
CSI 0.3rCSI 0.5%PRS 9.9%
-
CSI 0.3rCSI 0.4%PRS 14.5%
-
CSI 0.3rCSI 0.8%PRS 11.8%
-
CSI 0.3rCSI 1.1%PRS 9.1%
-
CSI 0.4rCSI 1.1%PRS 14.4%
-
CSI 0.4rCSI 7.2%PRS 71.4%
-
CSI 0.4rCSI 0.6%PRS 12.5%
-
CSI 0.4rCSI 0.7%PRS 25.1%
-
CSI 0.4rCSI 1.9%PRS 30.3%
-
CSI 0.4rCSI 1.4%PRS 21.4%
-
CSI 0.4rCSI 2.3%PRS 39.7%
-
CSI 0.4rCSI 8.5%PRS 10.7%
-
CSI 0.4rCSI 0.5%PRS 16.9%
-
CSI 0.5rCSI 5.0%PRS 24.5%
-
CSI 0.5rCSI 0.7%PRS 20.7%
-
CSI 0.5rCSI 0.5%PRS 11.8%
-
CSI 0.5rCSI 0.6%PRS 12.6%
-
CSI 0.5rCSI 0.4%PRS 22.4%
-
CSI 0.5rCSI 1.5%PRS 40.6%
-
CSI 0.5rCSI 3.0%PRS 19.1%
-
CSI 0.5rCSI 1.3%PRS 20.1%
-
CSI 0.5rCSI 1.8%PRS 46.7%
-
CSI 0.5rCSI 3.2%PRS 28.2%
-
CSI 0.5rCSI 1.3%PRS 19.0%
-
CSI 0.5rCSI 0.6%PRS 14.9%
-
CSI 0.6rCSI 1.6%PRS 9.9%
-
CSI 0.6rCSI 8.1%PRS 8.8%
-
CSI 0.6rCSI 0.7%PRS 16.0%
-
CSI 0.6rCSI 0.9%PRS 9.8%
-
CSI 0.6rCSI 2.3%PRS 26.2%
-
CSI 0.6rCSI 1.3%PRS 9.2%
-
CSI 0.6rCSI 0.8%PRS 11.8%
-
CSI 0.6rCSI 1.7%PRS 19.6%
-
CSI 0.6rCSI 4.0%PRS 12.9%
-
CSI 0.6rCSI 3.4%PRS 46.6%
-
CSI 0.6rCSI 1.6%PRS 11.9%
-
CSI 0.6rCSI 1.2%PRS 33.1%
-
CSI 0.6rCSI 1.3%PRS 25.7%
-
CSI 0.6rCSI 0.7%PRS 23.6%
-
CSI 0.6rCSI 2.1%PRS 18.6%
-
CSI 0.7rCSI 3.0%PRS 55.5%
-
CSI 0.7rCSI 1.7%PRS 11.7%
-
CSI 0.7rCSI 4.1%PRS 49.1%
-
CSI 0.7rCSI 0.9%PRS 30.5%
-
CSI 0.7rCSI 3.3%PRS 16.3%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1440314806
Symbol: CD47_HUMAN
Name: Leukocyte surface antigen CD47
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 1394148
Title: An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains.
PubMed ID: 1394148
PubMed ID: 7691831
Title: Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane spanning domains implicated in alpha-v beta-3-dependent ligand binding.
PubMed ID: 7691831
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 7998989
Title: Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3.
PubMed ID: 7998989
DOI: 10.1042/bj3040525
PubMed ID: 8550562
Title: Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.
PubMed ID: 8550562
DOI: 10.1074/jbc.271.1.21
PubMed ID: 10549293
Title: Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane.
PubMed ID: 10549293
PubMed ID: 11454874
Title: Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains.
PubMed ID: 11454874
PubMed ID: 11509594
Title: Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation.
PubMed ID: 11509594
PubMed ID: 15383453
Title: Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation.
PubMed ID: 15383453
PubMed ID: 15917238
PubMed ID: 19004835
Title: Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
PubMed ID: 19004835
PubMed ID: 19159218
Title: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.
PubMed ID: 19159218
DOI: 10.1021/pr8008012
PubMed ID: 19349973
Title: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.
PubMed ID: 19349973
DOI: 10.1038/nbt.1532
PubMed ID: 22079249
Title: Integrin-associated protein (CD47) is a putative mediator for soluble fibrinogen interaction with human red blood cells membrane.
PubMed ID: 22079249
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 27742621
Title: TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.
PubMed ID: 27742621
DOI: 10.1093/cvr/cvw218
PubMed ID: 32679764
Title: CD47 Promotes Age-Associated Deterioration in Angiogenesis, Blood Flow and Glucose Homeostasis.
PubMed ID: 32679764
DOI: 10.3390/cells9071695
PubMed ID: 18657508
Title: Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47.
PubMed ID: 18657508
Sequence Information:
- Length: 323
- Mass: 35214
- Checksum: 5D20730A2632D550
- Sequence:
MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVASNQKTIQ PPRKAVEEPL NAFKESKGMM NDE
Genular Protein ID: 272715215
Symbol: A0A0A1TSG4_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 293
- Mass: 31872
- Checksum: E841A2F6696D11F4
- Sequence:
MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVE